vimarsana.com
Home
Live Updates
FDA approves first human gene editing therapy for sickle cel
FDA approves first human gene editing therapy for sickle cel
FDA approves first human gene editing therapy for sickle cell disease
The Food and Drug Administration Friday approved a new sickle cell disease treatment using the CRISPR genome editing technology. It's the first approved human gene editing therapy.
Related Keywords
United States ,
Tennessee ,
Americans ,
Peter Marks ,
Rabi Hanna ,
Nicole Verdun ,
Jennelle Stephenson ,
Drug Administration On ,
Drug Administration ,
Black Americans ,
Cleveland Clinic ,
Sickle Cell Disease ,
Gene Editing ,
Fda ,
Red Blood Cells ,
Gene Therapies ,
Rare Diseases ,
Rispr Genome Editing ,